Integrating Gene Correction in the Reprogramming and Transdifferentiation Processes: A One-Step Strategy to Overcome Stem Cell-Based Gene Therapy Limitations
The recent advent of induced pluripotent stem cells (iPSCs) and gene therapy tools has raised the possibility of autologous cell therapy for rare genetic diseases. However, cellular reprogramming is inefficient in certain diseases such as ataxia telangiectasia, Fanconi anemia, LIG4 syndrome, and fib...
Saved in:
| Main Authors: | Seo-Young Lee, Sun-Ku Chung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2016/2725670 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanical Cell Reprogramming on Tissue-Mimicking Hydrogels for Cancer Cell Transdifferentiation
by: Xueqing Ren, et al.
Published: (2025-01-01) -
Endothelial transdifferentiation of glioma stem cells: a literature review
by: Andrei Buruiana, et al.
Published: (2025-08-01) -
Identification of Key Hub Genes Associated with Breast Cancer Stem Cells to Overcome Therapy Resistance
by: Mobina Khorshidi, et al.
Published: (2025-06-01) -
Podocyte epithelial-mesenchymal transdifferentiation and glomerular disease
by: CHEN Hai-yun, et al.
Published: (2020-01-01) -
ANIMAL MODELS FOR LINEAGE TRACING IN (CELL) TRANSDIFFERENTIATION
Published: (2025-08-01)